Prostate Cancer

This study shows a big cause of inflammation in common bowel disease

In a recent study from Weill Cornell Medicine, researchers found a type of gut bacteria that causes intestinal inflammation in patients with Crohn’s disease,...

Having a single personal doctor may lead to unnecessary tests

Patient care by a single primary care physician is linked to many health benefits, including increased treatment adherence and decreased hospital admissions and mortality...

This common vegetable may slow down probate cancer growth

In a new study, researchers found that the chemicals present in white button mushrooms may slow the progression of prostate cancer. Androgens, a type of...

New drug could cut bladder cancer death risk by 30%

In a new study, researchers found that a new type of drug can increase the survival of patients with the most common form of...

This daily beverage may lower prostate cancer risk

Prostate cancer is the second most common cancer and the sixth leading cause of cancer death in men. Nearly three out of four cases occur...

New prostate cancer test could avoid unnecessary biopsies

A urine test based on University of Michigan Rogel Cancer Center research could have avoided one third of unnecessary prostate cancer biopsies while failing...

This common beverage linked to lower prostate cancer risk

In a new study, researchers found that drinking several cups of coffee every day may be linked to a lower risk of developing prostate...

MRI often underestimates tumor size in prostate cancer

In a new study, researchers found that magnetic resonance imaging, or MRI, frequently underestimates the size of prostate tumors, potentially leading to under-treatment. The research...

This healthy diet may reduce prostate cancer development

In a new study, researchers found that men with prostate cancer who had a Mediterranean-style diet fared better over the course of their disease. The...

Why some prostate cancer can resist treatment

In a new study, researchers found a new mechanism in which prostate cancer cells can 'switch' character and become resistant to therapy. These findings are...